New Biogen data showed no major safety issues for its Alzheimer's drug

  • 📰 Reuters
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Biogen Inc on Thursday presented new data on its experimental Alzheimer's d...

FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File Photo

It has been at least 15 years since the FDA has reviewed an application for a new Alzheimer’s treatment, and an agent that can slow progression of the mind-wasting disease is desperately needed. “All of the data suggests this is a disease modification. That means the impact of the treatment will continue to accrue with time,” said Dr. Paul Aisen, an Alzheimer’s expert from the University of Southern California.

Biogen’s shares had been halted prior to the presentation at a Alzheimer’s meeting, reopened lower, and then rose as investors tried to parse the meeting from the complicated study.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Just like Boeing!

Tested for only one day

It investigated itself and found no issues. It has to be fine.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Biogen's stock rises 4% after releasing new data on late-stage Alzheimer's drugAnalysts who parsed through it, said the lack of any new negatives in the report means that they expect the company will take the data to the Food and Drug Administration. I predict in 10-20 years from now, we weill look upon this moment and realized they faked their data. They knew it wouldn’t work, but wanted to recouo losses. You heard it here first.
Source: CNBC - 🏆 12. / 72 Read more »

Drug curbs delusions, eases anger in Alzheimer's patients, researchers findIf regulators approve it, the drug could become the first new medicine for Alzheimer's patients in nearly two decades. wow, my grandma died of alzheimers. it's great to see the steps they've taken in recent years to find a cure. I know were a long way off, but itz always uplifting to see articles like this. navgirl63 Can we start putting this in Trump's Happy Meals? Now for a President BernieSanders and MedicareForAll to make this affordable for all. Medicare Fro All will have a $250 annual max cap on prescriptions.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Over half a million marijuana vapes seized in the U.S. in the last 2 yearsThe pursuit of pot cartridges has added a new layer to drug enforcement while authorities are grappling with the opioid crisis and other drug issues. Give them to me so I can dispose of them properly!
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

Major consumer groups ask FTC to look into 'predatory' data collection of childrenIn a letter to the FTC, the consumer groups ask the agency to look at digital media companies' data collection practices.
Source: CNBC - 🏆 12. / 72 Read more »

Shares of biotech Aurinia more than double in one day after positive data for Lupus drugThe Victoria, Canada-based company rallied after its trial for drug voclosporin posted positive efficacy and safety results.
Source: CNBC - 🏆 12. / 72 Read more »